BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cui YH, Yang S, Wei J, Shea CR, Zhong W, Wang F, Shah P, Kibriya MG, Cui X, Ahsan H, He C, He YY. Autophagy of the m6A mRNA demethylase FTO is impaired by low-level arsenic exposure to promote tumorigenesis. Nat Commun 2021;12:2183. [PMID: 33846348 DOI: 10.1038/s41467-021-22469-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang F, Zhang A. Role of N6-methyladenosine RNA modification in the imbalanced inflammatory homeostasis of arsenic-induced skin lesions. Environ Toxicol 2022. [PMID: 35363433 DOI: 10.1002/tox.23530] [Reference Citation Analysis]
2 Wang N, Huo X, Zhang B, Chen X, Zhao S, Shi X, Xu H, Wei X. METTL3-Mediated ADAMTS9 Suppression Facilitates Angiogenesis and Carcinogenesis in Gastric Cancer. Front Oncol 2022;12:861807. [PMID: 35574388 DOI: 10.3389/fonc.2022.861807] [Reference Citation Analysis]
3 Chen Z, Hu Y, Jin L, Yang F, Ding H, Zhang L, Li L, Pan T. The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance. Front Pharmacol 2022;13:873030. [PMID: 35462896 DOI: 10.3389/fphar.2022.873030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li W, Deng X, Chen J. RNA-binding Proteins in Regulating mRNA Stability and Translation: Roles and Mechanisms in Cancer. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.03.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Xiao Q, Lei L, Ren J, Peng M, Jing Y, Jiang X, Huang J, Tao Y, Lin C, Yang J, Sun M, Tang L, Wei X, Yang Z, Zhang L. Mutant NPM1-Regulated FTO-Mediated m6A Demethylation Promotes Leukemic Cell Survival via PDGFRB/ERK Signaling Axis. Front Oncol 2022;12:817584. [PMID: 35211409 DOI: 10.3389/fonc.2022.817584] [Reference Citation Analysis]
6 Maimaiti A, Tuersunniyazi A, Meng X, Pei Y, Ji W, Feng Z, Jiang L, Wang Z, Kasimu M, Wang Y, Shi X. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma. Front Genet 2022;13:872186. [DOI: 10.3389/fgene.2022.872186] [Reference Citation Analysis]
7 Liu L, Li H, Hu D, Wang Y, Shao W, Zhong J, Yang S, Liu J, Zhang J. Insights into N6-methyladenosine and programmed cell death in cancer. Mol Cancer 2022;21:32. [PMID: 35090469 DOI: 10.1186/s12943-022-01508-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
8 Gao M, Qi Z, Feng W, Huang H, Xu Z, Dong Z, Xu M, Han J, Kloeber JA, Huang J, Lou Z, Liu S. m6A demethylation of cytidine deaminase APOBEC3B mRNA orchestrates arsenic-induced mutagenesis. J Biol Chem 2022;298:101563. [PMID: 34998823 DOI: 10.1016/j.jbc.2022.101563] [Reference Citation Analysis]
9 Wilkinson E, Cui YH, He YY. Roles of RNA Modifications in Diverse Cellular Functions. Front Cell Dev Biol 2022;10:828683. [PMID: 35350378 DOI: 10.3389/fcell.2022.828683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Chen X, Wang J, Tahir M, Zhang F, Ran Y, Liu Z, Wang J. Current insights into the implications of m6A RNA methylation and autophagy interaction in human diseases. Cell Biosci 2021;11:147. [PMID: 34315538 DOI: 10.1186/s13578-021-00661-x] [Reference Citation Analysis]
11 Rashdan HRM, Shehadi IA, Chen T. Triazoles Synthesis & Applications as Nonsteroidal Aromatase Inhibitors for Hormone-Dependent Breast Cancer Treatment. Heteroatom Chemistry 2022;2022:1-16. [DOI: 10.1155/2022/5349279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Qiu T, Wu C, Yao X, Han Q, Wang N, Yuan W, Zhang J, Shi Y, Jiang L, Liu X, Yang G, Sun X. AS3MT facilitates NLRP3 inflammasome activation by m6A modification during arsenic-induced hepatic insulin resistance. Cell Biol Toxicol 2022. [PMID: 35226250 DOI: 10.1007/s10565-022-09703-7] [Reference Citation Analysis]
13 Zhang M, Zhang N, Lu X, Li W, Wang R, Chang J. Comparative study of the binding between chlorogenic acid and four proteins by isothermal titration calorimetry, spectroscopy and docking methods. Pharmacol Rep 2022. [PMID: 35545727 DOI: 10.1007/s43440-022-00369-w] [Reference Citation Analysis]
14 Song N, Cui K, Zhang K, Yang J, Liu J, Miao Z, Zhao F, Meng H, Chen L, Chen C, Li Y, Shao M, Zhang J, Wang H. The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research. Front Pharmacol 2022;13:933332. [DOI: 10.3389/fphar.2022.933332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Cen Y, Zhu T, Zhang Y, Zhao L, Zhu J, Wang L, Xu J, Ding T, Xie X, Wang X, Lu W. hsa_circ_0005358 suppresses cervical cancer metastasis by interacting with PTBP1 protein to destabilize CDCP1 mRNA. Mol Ther Nucleic Acids 2022;27:227-40. [PMID: 34976440 DOI: 10.1016/j.omtn.2021.11.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Verghese M, Wilkinson E, He YY. Role of RNA modifications in carcinogenesis and carcinogen damage response. Mol Carcinog 2022. [PMID: 35560957 DOI: 10.1002/mc.23418] [Reference Citation Analysis]
17 Liu C, Yang S, Zhang Y, Wang C, Du D, Wang X, Liu T, Liang G. Emerging Roles of N6-Methyladenosine Demethylases and Its Interaction with Environmental Toxicants in Digestive System Cancers. Cancer Manag Res 2021;13:7101-14. [PMID: 34526822 DOI: 10.2147/CMAR.S328188] [Reference Citation Analysis]
18 Feng Y, Liu T, Xu S, Ren Y, Ge Y, Yin L, Pu Y, Liang G. The role of N6-methyladenosine methylation in environmental exposure-induced health damage. Environ Sci Pollut Res Int 2022. [PMID: 35951238 DOI: 10.1007/s11356-022-22093-x] [Reference Citation Analysis]
19 Wu S, Li XF, Wu YY, Yin SQ, Huang C, Li J. N6 -Methyladenosine and Rheumatoid Arthritis: A Comprehensive Review. Front Immunol 2021;12:731842. [PMID: 34630412 DOI: 10.3389/fimmu.2021.731842] [Reference Citation Analysis]
20 Huang C, Zhang K, Guo Y, Shen C, Liu X, Huang H, Dou X, Yu B. The crucial roles of m6A RNA modifications in cutaneous cancers: Implications in pathogenesis, metastasis, drug resistance, and targeted therapies. Genes & Diseases 2022. [DOI: 10.1016/j.gendis.2022.03.006] [Reference Citation Analysis]
21 Zhi Y, Zhang S, Zi M, Wang Y, Liu Y, Zhang M, Shi L, Yan Q, Zeng Z, Xiong W, Zhi K, Gong Z. Potential applications of N6 -methyladenosine modification in the prognosis and treatment of cancers via modulating apoptosis, autophagy, and ferroptosis. Wiley Interdiscip Rev RNA 2022;:e1719. [PMID: 35114735 DOI: 10.1002/wrna.1719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Song W, Ren J, Yuan W, Xiang R, Ge Y, Fu T. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients. Genes (Basel) 2021;12:1375. [PMID: 34573357 DOI: 10.3390/genes12091375] [Reference Citation Analysis]
23 Fu J, Cui X, Zhang X, Cheng M, Li X, Guo Z, Cui X. The Role of m6A Ribonucleic Acid Modification in the Occurrence of Atherosclerosis. Front Genet 2021;12:733871. [PMID: 34603394 DOI: 10.3389/fgene.2021.733871] [Reference Citation Analysis]
24 Wang R, Wang L, Wang L, Cui Z, Cheng F, Wang W, Yang X. FGF2 Is Protective Towards Cisplatin-Induced KGN Cell Toxicity by Promoting FTO Expression and Autophagy. Front Endocrinol 2022;13:890623. [DOI: 10.3389/fendo.2022.890623] [Reference Citation Analysis]
25 Ruan Y, Fang X, Guo T, Liu Y, Hu Y, Wang X, Hu Y, Gao L, Li Y, Pi J, Xu Y. Metabolic reprogramming in the arsenic carcinogenesis. Ecotoxicol Environ Saf 2021;229:113098. [PMID: 34952379 DOI: 10.1016/j.ecoenv.2021.113098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]